6.
Domnich A, Grassi R, Fallani E, Spurio A, Bruzzone B, Panatto D
. Changes in Attitudes and Beliefs Concerning Vaccination and Influenza Vaccines between the First and Second COVID-19 Pandemic Waves: A Longitudinal Study. Vaccines (Basel). 2021; 9(9).
PMC: 8470379.
DOI: 10.3390/vaccines9091016.
View
7.
Viswanath K, Bekalu M, Dhawan D, Pinnamaneni R, Lang J, McLoud R
. Individual and social determinants of COVID-19 vaccine uptake. BMC Public Health. 2021; 21(1):818.
PMC: 8081000.
DOI: 10.1186/s12889-021-10862-1.
View
8.
Cunningham-Erves J, George W, Sanderson M, Stewart E, Jin S, Davis J
. Predictors of seasonal influenza and COVID-19 vaccination coverage among adults in Tennessee during the COVID-19 pandemic. Front Public Health. 2024; 12:1321173.
PMC: 10945017.
DOI: 10.3389/fpubh.2024.1321173.
View
9.
Tzenios N, Tazanios M, Chahine M
. Combining Influenza and COVID-19 Booster Vaccination Strategy to Improve Vaccination Uptake Necessary for Managing the Health Pandemic: A Systematic Review and Meta-Analysis. Vaccines (Basel). 2023; 11(1).
PMC: 9860577.
DOI: 10.3390/vaccines11010016.
View
10.
Sherman S, Smith L, Sim J, Amlot R, Cutts M, Dasch H
. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2020; 17(6):1612-1621.
PMC: 8115754.
DOI: 10.1080/21645515.2020.1846397.
View
11.
Della Polla G, Miraglia Del Giudice G, Pelullo C, Angelillo I
. Bivalent second booster dose of the COVID-19 vaccine: Eligible populations' reasons for receiving in Italy. Hum Vaccin Immunother. 2023; 19(1):2188856.
PMC: 10088915.
DOI: 10.1080/21645515.2023.2188856.
View
12.
Garza N, Leibensperger M, Bonnevie E
. The Association Between Receiving the Flu and COVID-19 Vaccines and Related Factors, Data from the StopFlu Campaign in Eight States and the District of Columbia, 2022. J Community Health. 2023; 48(4):731-739.
PMC: 10066005.
DOI: 10.1007/s10900-023-01213-9.
View
13.
Sansone V, Miraglia Del Giudice G, Della Polla G, Angelillo I
. Knowledge, Attitudes, and Coverage of Recommended Vaccinations in Individuals with Chronic Medical Conditions: A Cross-Sectional Telephone Survey in Italy. Vaccines (Basel). 2024; 12(3).
PMC: 10974983.
DOI: 10.3390/vaccines12030336.
View
14.
Andrejko K, Myers J, Openshaw J, Fukui N, Li S, Watt J
. Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season. Vaccine. 2022; 41(6):1190-1197.
PMC: 9780637.
DOI: 10.1016/j.vaccine.2022.12.052.
View
15.
Trent M, Salmon D, MacIntyre C
. Predictors of pneumococcal vaccination among Australian adults at high risk of pneumococcal disease. Vaccine. 2022; 40(8):1152-1161.
DOI: 10.1016/j.vaccine.2022.01.011.
View
16.
McGrath L, Malhotra D, Miles A, Welch V, Di Fusco M, Surinach A
. Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine. JAMA Netw Open. 2023; 6(11):e2342151.
PMC: 10632958.
DOI: 10.1001/jamanetworkopen.2023.42151.
View
17.
Costantino C, Mazzucco W, Conforto A, Cimino L, Pieri A, Rusignolo S
. Real-life experience on COVID-19 and seasonal influenza vaccines co-administration in the vaccination hub of the University Hospital of Palermo, Italy. Hum Vaccin Immunother. 2024; 20(1):2327229.
PMC: 10950263.
DOI: 10.1080/21645515.2024.2327229.
View
18.
Harris D, Chachlani P, Hayes K, McCarthy E, Wen K, Deng Y
. COVID-19 and Influenza Vaccine Coadministration Among Older U.S. Adults. Am J Prev Med. 2024; 67(1):67-78.
PMC: 11193626.
DOI: 10.1016/j.amepre.2024.02.013.
View
19.
Della Polla G, Licata F, Angelillo S, Pelullo C, Bianco A, Angelillo I
. Characteristics of Healthcare Workers Vaccinated against Influenza in the Era of COVID-19. Vaccines (Basel). 2021; 9(7).
PMC: 8310005.
DOI: 10.3390/vaccines9070695.
View
20.
Della Polla G, Miraglia Del Giudice G, Postiglione M, Angelillo I
. Parents' Uptake and Willingness towards Recommended Vaccinations for Their Children with Underlying Chronic Medical Conditions in Italy. Vaccines (Basel). 2023; 11(9).
PMC: 10536001.
DOI: 10.3390/vaccines11091423.
View